Longevity Today
Academic PapersReviewsVideosPodcastsPress ReleasesClinical TrialsDrug ApprovalsTutorialsAnimations
All Articles
Sign In
Deep Dive Audio
Frog Bacterium Wipes Out Cancer Tumors in Mice with One DoseCancer Research

Frog Bacterium Wipes Out Cancer Tumors in Mice with One Dose

Scientists at Japan's JAIST discovered that a bacterium from Japanese tree frog intestines can completely eliminate colorectal cancer tumors in mice with a single intravenous dose. The bacterium, Ewingella americana, achieved a 100% complete response rate in the mouse model, outperforming standard treatments including immune checkpoint inhibitors and chemotherapy. It works through two mechanisms: multiplying inside oxygen-deprived tumor tissue and activating immune cells like T cells, B cells, and neutrophils to attack cancer. Crucially, the bacteria concentrated almost exclusively in tumors and avoided healthy organs, suggesting a favorable safety profile. While results are limited to mice, researchers believe this living bacterial therapy could one day be adapted to treat many types of solid tumors in humans.

0:00--:--
Read Full Article
Longevity Today

Developed by the Clinical and Foundational Medicine Institute

AI-powered summaries of the world's best longevity research — from peer-reviewed journals to expert podcasts and YouTube deep-dives. Built for those who take their healthspan seriously.

info@LongevityToday.com

Categories

CancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced Therapies

Platform

  • All Articles
  • Membership Plans
  • Search
  • Newsletter

Newsletter

Weekly longevity research, summarized.

Enter your email to subscribe:

© 2026 Longevity Today. All rights reserved.

About UsPrivacy PolicyTerms of UseMedical Disclaimer

Content on Longevity Today is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making health decisions.